胺碘酮与普罗帕酮在快速性心律失常患者院前急救效果中的对比分析

Comparative analysis of amiodarone and properazone in patients with rapid arrhythmia

ES评分 0

DOI 10.12208/j.ijcr.20220424
刊名
International Journal of Clinical Research
年,卷(期) 2022, 6(8)
作者
作者单位

西安630医院 陕西西安 ;

摘要
比较快速性心律失常患者院前急救中应用胺碘酮与普罗帕酮治疗的效果。方法 择取本院急诊科院前急救中收治的快速性心律失常患者进行研究,共计100例,收治时间为2020年1月至2021年12月。采用计算机抽号方式随机分组,分对胺碘组(n=50)、普罗帕组(n=50)。胺碘组采用胺碘酮治疗,普罗帕组采用普罗帕酮治疗。比较两组治疗效果、用药不良反应发生率以及治疗前后的HRV参数指标水平。结果 胺碘组患者治疗有效率98.00%,高于普罗帕组(P<0.05)。胺碘组用药不良反应4.00%,低于普罗帕组(P<0.05)。胺碘组治疗后sDNNindex、SDNN、rMSSD水平高于普罗帕组(P<0.05)。结论 快速性心律失常患者院前急救中采用胺碘酮治疗效果优于普罗帕酮治疗,且用药安全性更高,建议首选。
Abstract
Objective To compare the effect of amiodarone and proparadenone treatment in prehospital emergency treatment in patients with rapid arrhythmia. Methods The patients admitted in the emergency department were 100 patients from January 2020 to December 2021. The group was randomly ized by computer into amine iodine group (n=50) and Proa group (n=50). The amine iodinated group was treated with amiodarone and the propa group was treated with propadone. The treatment effect, the incidence of adverse drug reactions, and the index level of HRV parameters before and after treatment were compared between the two groups. Results The response rate of treatment was 98.00%, higher than that of Proa group (P <0.05). Adverse reactions in amine iodine group were 4.00%, which was lower than that in proa group (P <0.05). The levels of sDNNindex, SDNN and rMSSD were higher in the amine-iodine group than in the proa group (P <0.05). Conclusion Amiodarone is better than properazenone, and the drug safety is recommended.
关键词
胺碘酮;普罗帕酮;快速性心律失常;院前急救;治疗效果
KeyWord
Amiodarone; Properazone; Rapid Arrhythmia; Pre-Hospital First Aid; Treatment Effect
基金项目
页码 163-166
  • 参考文献
  • 相关文献
  • 引用本文

李菲*. 胺碘酮与普罗帕酮在快速性心律失常患者院前急救效果中的对比分析 [J]. 国际临床研究杂志. 2022; 6; (8). 163 - 166.

  • 文献评论

相关学者

相关机构